Evidence map›Paper›PMID 39050227›Full record

ArticleOpen forum infectious diseases2024

Impact of an Intervention Program on

Sara Kamel, María Dolores Corbacho-Loarte, Rosa Escudero-Sánchez, Ana Halperin, Sergio Llorente, Sara María Quevedo, Cecilia Suárez-Carantoña, Laura Del Campo, María Soledad Hernández, Santiago Moreno Guillen and 1 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sara KamelInternal Medicine Department, Hospital Universitario Severo Ochoa, Madrid, Spain.
María Dolores Corbacho-LoarteInfectious Diseases Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.ORCID https://orcid.org/0000-0002-1674-6304
Rosa Escudero-SánchezInfectious Diseases Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
Ana HalperinMicrobiology Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
Sergio LlorenteInternal Medicine Department, Hospital Universitario Severo Ochoa, Madrid, Spain.
Sara María QuevedoMicrobiology Department, Hospital Universitario Severo Ochoa, IRYCIS, Madrid, Spain.
Cecilia Suárez-CarantoñaIInternal Medicine Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
Laura Del CampoBiostatistics Department, CIBERESP, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
María Soledad HernándezInternal Medicine Department, Hospital General de Elda, Alicante, Spain.
Santiago Moreno GuillenInfectious Diseases Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
Javier CoboInfectious Diseases Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We studied a cohort of patients with a positive test result for toxigenic Results: Hospital A avoided more unnecessary treatments (19.3% vs 11.5%), provided access to novel therapies more frequently (35.3% vs 13%), and adhered more closely to current guidelines (95.8% vs 71.3%). Although the mortality and recurrence rates did not differ, the absence of an intervention program was associated with greater odds of admission due to recurrence (odds ratio, 4.19; Conclusions: Implementation of a CDI intervention program based on recommendations from IDSs and improved access to specialized care during the follow-up is associated with enhanced quality of CDI management and potential reductions in hospital resource utilization.

Indexed as

CDI readmissionsCDI recurrenceClostridioides difficile infectioncontinuity of careIDS value

Identifiers

PMID39050227
PMCPMC11267231

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.